Page last updated: 2024-11-03

propantheline and Urethral Diseases

propantheline has been researched along with Urethral Diseases in 1 studies

Propantheline: A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking.

Urethral Diseases: Pathological processes involving the URETHRA.

Research Excerpts

ExcerptRelevanceReference
"Forty-three children with overt neurological disease and neuropathic vesicourethral dysfunction were entered into a trial comparing clean intermittent catheterisation (CIC) with manual expression combined with drug treatment (non-CIC)."2.65Neuropathic vesicourethral dysfunction in children. A trial comparing clean intermittent catheterisation with manual expression combined with drug treatment. ( Borzyskowski, M; Chantler, C; Haycock, GB; Joyce, MR; Kinder, CH; Mundy, AR; Neville, BG; Park, L, 1982)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borzyskowski, M1
Mundy, AR1
Neville, BG1
Park, L1
Kinder, CH1
Joyce, MR1
Chantler, C1
Haycock, GB1

Trials

1 trial available for propantheline and Urethral Diseases

ArticleYear
Neuropathic vesicourethral dysfunction in children. A trial comparing clean intermittent catheterisation with manual expression combined with drug treatment.
    British journal of urology, 1982, Volume: 54, Issue:6

    Topics: Bethanechol Compounds; Child; Clinical Trials as Topic; Ephedrine; Follow-Up Studies; Humans; Phenox

1982